Global Vasotocin 麻豆原创 Research Report 2024

Publication ID:

PB503245526

Publication Date:

March 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Angioconstrictin, also known as angioconstrictin or angiotensin, is an oligopeptide hormone that is an important part of the renin-angiotensin system.
The global Vasotocin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Vasotocin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vasotocin.
Report Scope
The Vasotocin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vasotocin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vasotocin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Peptide Institute
Genscript
Abcam
PerkinElmer
Fisher Scientific
Segment by Type
Above 95%
Above 99%
Segment by Application
Scientific Research
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vasotocin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vasotocin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vasotocin 麻豆原创 Overview
1.1 Product Overview and Scope of Vasotocin
1.2 Vasotocin Segment by Type
1.2.1 Global Vasotocin 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Above 95%
1.2.3 Above 99%
1.3 Vasotocin Segment by Application
1.3.1 Global Vasotocin 麻豆原创 Value by Application: (2024-2030)
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Global Vasotocin 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vasotocin Revenue 2019-2030
1.4.2 Global Vasotocin Sales 2019-2030
1.4.3 Global Vasotocin 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vasotocin 麻豆原创 Competition by Manufacturers
2.1 Global Vasotocin Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Vasotocin Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Vasotocin Average Price by Manufacturers (2019-2024)
2.4 Global Vasotocin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vasotocin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vasotocin, Product Type & Application
2.7 Vasotocin 麻豆原创 Competitive Situation and Trends
2.7.1 Vasotocin 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vasotocin Players 麻豆原创 Share by Revenue
2.7.3 Global Vasotocin 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vasotocin Retrospective 麻豆原创 Scenario by Region
3.1 Global Vasotocin 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vasotocin Global Vasotocin Sales by Region: 2019-2030
3.2.1 Global Vasotocin Sales by Region: 2019-2024
3.2.2 Global Vasotocin Sales by Region: 2025-2030
3.3 Global Vasotocin Global Vasotocin Revenue by Region: 2019-2030
3.3.1 Global Vasotocin Revenue by Region: 2019-2024
3.3.2 Global Vasotocin Revenue by Region: 2025-2030
3.4 North America Vasotocin 麻豆原创 Facts & Figures by Country
3.4.1 North America Vasotocin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vasotocin Sales by Country (2019-2030)
3.4.3 North America Vasotocin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vasotocin 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vasotocin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vasotocin Sales by Country (2019-2030)
3.5.3 Europe Vasotocin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vasotocin 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Vasotocin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vasotocin Sales by Country (2019-2030)
3.6.3 Asia Pacific Vasotocin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vasotocin 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vasotocin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vasotocin Sales by Country (2019-2030)
3.7.3 Latin America Vasotocin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vasotocin 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vasotocin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vasotocin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vasotocin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vasotocin Sales by Type (2019-2030)
4.1.1 Global Vasotocin Sales by Type (2019-2024)
4.1.2 Global Vasotocin Sales by Type (2025-2030)
4.1.3 Global Vasotocin Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Vasotocin Revenue by Type (2019-2030)
4.2.1 Global Vasotocin Revenue by Type (2019-2024)
4.2.2 Global Vasotocin Revenue by Type (2025-2030)
4.2.3 Global Vasotocin Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Vasotocin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vasotocin Sales by Application (2019-2030)
5.1.1 Global Vasotocin Sales by Application (2019-2024)
5.1.2 Global Vasotocin Sales by Application (2025-2030)
5.1.3 Global Vasotocin Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Vasotocin Revenue by Application (2019-2030)
5.2.1 Global Vasotocin Revenue by Application (2019-2024)
5.2.2 Global Vasotocin Revenue by Application (2025-2030)
5.2.3 Global Vasotocin Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Vasotocin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Peptide Institute
6.1.1 Peptide Institute Corporation Information
6.1.2 Peptide Institute Description and Business Overview
6.1.3 Peptide Institute Vasotocin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Peptide Institute Vasotocin Product Portfolio
6.1.5 Peptide Institute Recent Developments/Updates
6.2 Genscript
6.2.1 Genscript Corporation Information
6.2.2 Genscript Description and Business Overview
6.2.3 Genscript Vasotocin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genscript Vasotocin Product Portfolio
6.2.5 Genscript Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Corporation Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Vasotocin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abcam Vasotocin Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 PerkinElmer
6.4.1 PerkinElmer Corporation Information
6.4.2 PerkinElmer Description and Business Overview
6.4.3 PerkinElmer Vasotocin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PerkinElmer Vasotocin Product Portfolio
6.4.5 PerkinElmer Recent Developments/Updates
6.5 Fisher Scientific
6.5.1 Fisher Scientific Corporation Information
6.5.2 Fisher Scientific Description and Business Overview
6.5.3 Fisher Scientific Vasotocin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fisher Scientific Vasotocin Product Portfolio
6.5.5 Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vasotocin Industry Chain Analysis
7.2 Vasotocin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vasotocin Production Mode & Process
7.4 Vasotocin Sales and 麻豆原创ing
7.4.1 Vasotocin Sales Channels
7.4.2 Vasotocin Distributors
7.5 Vasotocin Customers
8 Vasotocin 麻豆原创 Dynamics
8.1 Vasotocin Industry Trends
8.2 Vasotocin 麻豆原创 Drivers
8.3 Vasotocin 麻豆原创 Challenges
8.4 Vasotocin 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Peptide Institute
Genscript
Abcam
PerkinElmer
Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.